» Articles » PMID: 36506774

Development of a Model for Early Differentiation of Adenovirus Pneumonia from Pneumonia

Overview
Journal Transl Pediatr
Specialty Pediatrics
Date 2022 Dec 12
PMID 36506774
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adenovirus pneumonia (AVP) and pneumonia (MPP) have similar clinical manifestations such as a high prevalence of lung consolidation, making the differential diagnosis difficult before the etiology is reported. This study aimed to compare AVP and MPP, and to build a predictive model to differentiate them early.

Methods: We selected 198 cases of AVP and 876 cases of MPP. Clinical manifestations, computed tomography (CT) features, and biomarkers were compared. A logistic regression model was built to predict AVP. The area under the curve (AUC) of the receiver-operating characteristic was calculated to evaluate the discriminant ability of the prediction model.

Results: Patients in the AVP group were mainly infants and toddlers, while the MPP group had more pre-school age children. The rate of hypoxemia and severe pneumonia was 3- and 11-times higher, respectively, in the AVP group than in the MPP group (5.6% 1.8%, 27.8% 2.5%, P<0.01). The proportion of patients with a Pediatric Logistic Organ Dysfunction-2 score ≥2 was 10 times higher in the AVP group than in the MPP group (17.4% 1.7%, P<0.01). Bilateral pneumonia was present in 90.2% of the AVP group. Biomarkers, such as interleukin (IL)-2 receptor, IL-10 and lactic dehydrogenase (LDH), were considerably higher in the AVP group than in the MPP group (P<0.01). The predictive model included eight variables, namely: age, severe pneumonia, bilateral pneumonia, ground-glass attenuation, consolidation, atelectasis, C-reactive protein, and LDH. The AUC was 86.6%.

Conclusions: Compared with MPP, AVP affects younger children, presents a more severe respiratory tract involvement, results in a larger range of lung lesions, and is associated with higher inflammatory biomarkers. Our predictive model includes a combination of clinical features, imaging findings, and biomarkers. It may help pediatricians in the early differentiation of AVP from MPP.

Citing Articles

Improvement of IL-4, IL-6, IL-10, TNF-α and IFN-γ in children with mycoplasma pneumonia through the combination of video scenario-based breathing training and antibiotics.

Zhang M Sleep Breath. 2025; 29(1):76.

PMID: 39806240 DOI: 10.1007/s11325-025-03244-z.


Construction of a predictive model of respiratory endoscopic intervention in children with lobar pneumonia caused by infection.

Li Y, Zhang J, Yang X, Wang T, Yan Y, Huang L Transl Pediatr. 2024; 13(7):1219-1230.

PMID: 39144426 PMC: 11320003. DOI: 10.21037/tp-24-245.


Severe Adenovirus Pneumonia Masked by Influenza Virus in an 11-Year-Old Child: A Case Report.

Shi Y, Ren Y Infect Drug Resist. 2024; 17:3395-3402.

PMID: 39131517 PMC: 11317053. DOI: 10.2147/IDR.S465870.

References
1.
Johnson D, Cunha B . Atypical pneumonias. Clinical and extrapulmonary features of Chlamydia, Mycoplasma, and Legionella infections. Postgrad Med. 1993; 93(7):69-72, 75-6, 79-82. DOI: 10.1080/00325481.1993.11701702. View

2.
Chkhaidze I, Kapanadze N . CYTOKINES AS THE PREDICTORS OF SEVERE MYCOPLASMA PNEUMONIAE PNEUMONIA IN CHILDREN (REVIEW). Georgian Med News. 2017; (267):89-95. View

3.
Shah S, Bachur R, Simel D, Neuman M . Does This Child Have Pneumonia?: The Rational Clinical Examination Systematic Review. JAMA. 2017; 318(5):462-471. DOI: 10.1001/jama.2017.9039. View

4.
Stanic B, Veen W, Wirz O, Ruckert B, Morita H, Sollner S . IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol. 2014; 135(3):771-80.e8. DOI: 10.1016/j.jaci.2014.07.041. View

5.
Lu A, Wang C, Zhang X, Wang L, Qian L . Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children. Respir Care. 2015; 60(10):1469-75. DOI: 10.4187/respcare.03920. View